Purpose: Alternative modes of cardiopulmonary exercise testing are needed and an arm cycle (AC) is a promising alternative to the gold standard of the leg cycle (LC). The aim of this study was to undertake a systematic review comparing maximal oxygen consumption (VO 2max ) obtained from AC and LC in patient populations with cardiovascular disease (CVD) and pulmonary disease (PD). Methods: A systematic review was undertaken with literature searches on December 5, 2016. Studies were included if they directly compared aerobic capacity values obtained from AC and LC in patients with CVD or PD. Results across studies were pooled using random effects meta-analysis and univariate meta-regression were used to assess potential associations between variables. Results: A total of 14 studies in 411 patients were included. On average, VO 2max of LC exceeded AC mean difference by 3.48 mL·kg 21 ·min 21 , (95% confidence interval [CI]: 1.94, 5.03) and a mean AC/ LC ratio of 0.83, (95% CI: 0.77, 0.90). VO 2max differences between AC and LC were similar in patients with CVD compared with PD but were found to be higher in older individuals and those with higher VO 2max . Conclusions: Although AC offers an important alternative form of exercise testing for patients with CVD or PD, clinicians must take into account that VO 2max values obtained from AC are consistently lower than those obtained on LC. However, the results of this article offer an evidence-based estimation for the proportional differences between AC values and LC values for groups with CVD or groups with PD. (Cardiopulm Phys Ther J. 2018;29: 154-165) Key Words: cardiopulmonary exercise testing, arm cycle, leg cycle, cardiovascular disease, chronic pulmonary disease, physical fitness, systematic review, meta-analysis 154 Tolstrup Larsen et al Cardiopulmonary Physical Therapy Journal
INTRODUCTION
Cardiopulmonary exercise testing (CPET) is the recommended noninvasive assessment of the physical fitness both in healthy populations as well as in the context of rehabilitation in various patient groups, including patients with cardiovascular disease (CVD) and pulmonary disease (PD). [1] [2] [3] [4] [5] When CPET is used in rehabilitation, it typically has 3 purposes: an objective measure of patients' physical fitness, a way of prescribing exercise intensity, and a measure of intervention-specific change over time. [1] [2] [3] Cardiopulmonary exercise testing is traditionally performed using lower limb exercise and often on a leg cycle (LC). [5] [6] [7] [8] However, patients with CVD and chronic obstructive pulmonary disease (COPD) may be unable to perform CPET on an LC due to lower limb comorbidities such as peripheral vascular disease, neurological disease among patients, 9 or loss of muscle mass in the lower limbs. 10 Alternative modes of delivery such as CPET performed using an arm cycle (AC) are therefore needed.
A recently published systematic review and metaanalysis in healthy adults reported a mean difference in oxygen uptake of 12.5 mL·kg 21 ·min 21 favoring LC compared with AC, and a linear relationship with a ratio of 0.7 between the tests. 11 This systematic review was limited to studies on healthy adults and it is uncertain whether the results are generalizable to patient populations. 11 Although there may be equations to estimate LC CPET values from AC obtained CPET values, these equations are expected to have a large amount of error. However, evidence within patient populations confirms the expected lower VO 2max measurements during AC-testing compared with LC-testing (eg, patients with vascular surgery, COPD, orthotropic cardiac transplants, and other CVD conditions), which can be explained by the use of a smaller amount of muscle mass when performing AC testing. 9, [12] [13] [14] In order for clinicians to use AC values to prescribe the correct exercise training intensity for patients with CVD or PD, the extent of the difference between obtained maximum values from AC and obtained maximum values from LC needs to be clarified.
The objective of this article is to undertake a systematic review and a meta-analysis of studies directly comparing aerobic capacity obtained from AC and LC in CVD and PD patient populations and subsequently to establish a ratio between AC and LC for use in everyday clinical practice.
METHOD
A protocol for this systematic review was published in the International Prospective Register of Systematic Reviews (PROSPERO-CRD42016048767), 15 and the reporting of the study was done according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. 16 
Criteria for Considering Studies for This Review
Types of Studies. Randomized controlled trials, observational cohort studies, cross-sectional studies, and casecontrol studies were considered eligible for inclusion. Types of Patients. The following patient groups were included: Patients with CVD according to the World Health Organization (WHO) definition, ie, coronary heart disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism.
unobtainable studies or studies with missing data were contacted.
Two authors (R.T.L. and C.K.) independently screened titles and abstracts and assessed eligible articles in full-text. Any inconsistencies between authors were solved by discussion and, if relevant, a third author (L.T.) was consulted.
Data Extraction
The following information was extracted from included studies: sample size, study design, patient population (CVD or PD), sex distribution, mean age, mean height, mean weight, mean body mass index (BMI), highest obtained VO 2 . However, older studies tend to report the absolute VO 2max instead of the body mass relative VO 2max .
11 Because of this and if possible, both types of outcome were extracted or calculated and used in the analyses. Two authors (R.T.L. and C.K.) independently extracted the above listed data from all included studies. Any inconsistencies between authors was discussed and solved with consultation of a third author (L.T.).
Risk of Bias Assessment
The Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies 19 was used as a template for assessing the methodological quality of all included studies. Quality assessment items 5 and 9 to 12 (groups recruited from the same population, concurrent controls, exposure assessment priori outcome assessment, exposure measures and assessment, and blinding of exposure assessor) were not applicable for the research question in this review and the items did not contribute to the quality rating. Each item was assessed for "low risk," "unclear risk," or "high risk" of bias. Two authors (R.T.L. and C.K.) independently undertook the quality assessment. Any inconsistencies between authors were solved by discussion and, if relevant, a third author (L.T.) was consulted. The risk of bias assessment was performed rigorously according to the PROSPERO protocol. 15 
Data Analysis
Two studies included more than one group in the CPET (men/women or different groups in a randomized controlled trial) and hence did also report values for the specific groups. 12, 20 Because of this, the analyses were performed with the results of the specific groups. 21 As no studies reported correlation values, we chose to impute a correlation value of 0.5 as it represents a moderate positive relationship between the test values, which was described in the protocol. 15 To obtain the values needed for the meta-analysis, the following calculation was performed for each individual study. With AC value be denoted as VO 2AC , LC value as VO 2LC , the correlation value as r, and the SDs as SD diff , SD AC , and SD LC .
We calculated the ratio and used the values in a metaanalysis to express the association between the 2 types of CPET. The ratio between the maximal obtained VO 2 from AC and from LC was calculated for each study as a ratio of the mean values. 22 Ratios below 1.0 favor the LC as having the largest values. To fully use the values in a metaanalysis, a logarithmic transformation was needed and the re-transformation was done in Stata using the eform command to get the pooled ratio and 95% confidence intervals (CIs). For a study reporting the values, let the ratio be denoted as VO 2ratio .
The levels of statistical heterogeneity were assessed using the I 2 score from each analysis. I 2 values from 0% to 25% were interpreted as the meta-analysis having a low level of heterogeneity, values from 26% to 50% as a moderate level, values from 51% to 75% as a high level, and from 76% to 100% as a considerable level. 23, 24 To avoid excluding studies from the meta-analyses, missing SDs were imputed from the median covariatespecific SD, respectively from CVD studies and PD studies, according to the Cochrane Handbook. 25 Subgroup analyses were performed by stratification on patient population (CVD or PD). Sensitivity analyses on L/min outcome were performed. Sensitivity analyses on small study bias were performed using the Egger test and, if significant, a metatrim analysis was performed to evaluate small study bias from imprecise studies. Meta-analyses stratified on the risk of bias assessment were used to evaluate if any heterogeneity in the analyses of the mean difference and the ratio was associated with methodological quality (low risk, unclear risk, or high risk).
Univariate meta-regressions were performed on the following continuous outcome measures: mean age, mean BMI (calculated for studies not reporting BMI), sex distribution (percentage of males), and mean difference in peak RER values. Size of aerobic capacity (based on the Astrand classification-"low," "fair," "average," "good," or "high") 26 was analyzed as a categorical outcome. All analyses were performed using Stata 14.0 software (StataCorp, 2013. Stata Statistical Software: Release 14.9; College Station, TX: StataCorp LP). Flowchart and risk of bias is presented using Review Manager 5.3 (Cochrane collaboration) software. A P value # .05 was considered as statistically significant.
RESULTS

Study Inclusion
The electronic searches identified 4154 records. After removing 707 duplicates, 3447 studies remained. Screening title and abstract resulted in exclusion of 3222 studies as they did not meet the CPET inclusion criteria, and thus, 225 studies were considered eligible for review in full text. In the full-text review, 211 studies were excluded in total; 118 were excluded due to lack of patients with CVD/PD, 25 for not reporting VO 2 values, 46 for lack of AC testing, 7 for lack of LC testing, 1 for lack of within-comparison design, 1 for lack of data, and 12 studies were unobtainable in full-text versions or only available in versions unable to translate (Persian, Turkish, and Japanese). Thus, 14 studies (published between 1971 and 2009) were included in the review. The study selection process is summarized in Figure 1 . Characteristics of the 14 included studies (17 groups, 411 participants) are listed in the Appendix, Supplemental Digital Content 1 (see Table 4 , http://links.lww.com/CPTJ/ A2). A summary of the included studies is listed in Table 1 .
Risk of Bias in Included Studies
Risk of bias in included studies is illustrated in detail in Figure 2 .
Mean Difference in Physical Fitness
The random-effects meta-analysis for the mean difference in mL·kg 21 ·min 21 is shown in Figure 3 
Sensitivity Analysis on Mean Difference Measured in L/min
Random-effects meta-analysis for the mean difference in L/min is shown in Figure 4 . All 17 groups from the 14 studies (411 participants) reported data for the mean difference measured in L/min. The overall mean difference was 0.25 L/min, (95% CI: 0. 13 
Sensitivity Analysis for Small Study Bias
The Egger test showed a significant result (P 5 .030) for mL·kg . This means that the smallest study reports the largest mean difference. The following metatrim analysis adjusted the overall mean difference to 1.95 mL·kg 
Analyses on the Ratios
The random-effects meta-analysis for the ratio is shown in Figure 5 . A total of 14 groups from 11 studies (349 participants) reported results in mL·kg 21 ·min 21 .
The overall ratio was 0.83, (95% CI: 0.77, 0.89), I 2 5 0%, P 5 .909, favoring LC. For patients with CVD, a pooled of ratio of 0.83, (95% CI: 0.75, 0.91), I
2 5 0%, P 5 .718, favoring LC was found. For patients with PD, a pooled 
Sensitivity Analysis on Results in L/min
The random-effects meta-analysis for the ratio is shown in Figure 6 . All 17 groups from the 14 studies (411 participants) reported results in L/min. The overall ratio was 0.83, (95% CI: 0.78, 0.89), I
2 5 0%, P 5 .937. For patients with CVD, a pooled ratio of 0.84, (95% CI: 0.77, 0.92), I
2 5 0%, P 5 .654, favoring LC was found. For patients with PD a pooled ratio of 0.83, (95% CI: 0.75, 0.92), I
2 5 0%, P 5 .959, favoring LC was found.
According
Sensitivity Analysis for Small Study Bias
The Egger test showed no significant result (P 
Univariate Meta-regressions on the Mean Difference
Results from univariate meta-regressions are shown in Table 2 (Fig. 3) and the metaanalysis on mean difference in L/min (Fig. 4) is explained by mean age and aerobic capacity. , stratified on cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; CHD, coronary heart disease; PAD, peripheral arterial disease; HF, heart failure, CT; cardiac transplant; CAD, coronary artery disease; LVRS, lung volume reduction surgery; COPD, chronic obstructive pulmonary disease. Fig. 4 . Random-effects meta-analysis on the mean difference between the arm cycle and the leg cycle reported as L/min, stratified on cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; CHD, coronary heart disease; PAD, peripheral arterial disease; HF, heart failure, CT; cardiac transplant; CAD, coronary artery disease; LVRS, lung volume reduction surgery; COPD, chronic obstructive pulmonary disease.
Univariate Meta-regressions on the Ratios
Results from univariate meta-regressions are shown in Table 3 , stratified on cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; CHD, coronary heart disease; PAD, peripheral arterial disease; HF, heart failure, CT; cardiac transplant; CAD, coronary artery disease; LVRS, lung volume reduction surgery; COPD, chronic obstructive pulmonary disease. Fig. 6 . Random-effects meta-analysis on the ratio between the arm cycle and the leg cycle reported as L/min, stratified on cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; CHD, coronary heart disease; PAD, peripheral arterial disease; HF, heart failure, CT; cardiac transplant; CAD, coronary artery disease; LVRS, lung volume reduction surgery; COPD, chronic obstructive pulmonary disease.
was found in the meta-analyses on the ratio from (Fig. 3) and L/min (Fig. 4) indicate that the mean differences were similar when comparing patients with CVD to patients with PD. The main finding of the meta-analyses on the ratios of the results in mL·kg 21 ·min 21 ( Fig. 5 ) and in L/min (Fig. 6) indicates that the ratio of 0.83 is similar when comparing patients with CVD to patients with PD. The sensitivity analysis and investigation for small study bias on mean difference in mL·kg 21 ·min 21 ( Fig. 3) indicate that the smallest study reports the largest mean difference. The metatrim analysis adjusted the mean difference for small study bias and imputed 3 fictive studies with mean differences favoring the AC. Although part of an appropriate analysis rationale, this imputation seems irrelevant as neither of our results nor previous findings in healthy adults 11 did indicate that groups of participants would obtain larger mean aerobic capacity from AC. Hereby, the most important information from this sensitivity analysis is that the smallest study is influencing the pooled mean difference toward a larger estimate.
The I 2 values from the analyses on the mean difference indicate considerable heterogeneity between the study results, whereas the I 2 values from the analyses on the ratios indicate no heterogeneity. The considerable heterogeneity found can be explained by the narrow CIs seen in Figures 3 and 4 and the nonexisting heterogeneity can be explained by the overlapping CIs seen in Figures 5 and 6 . 27 The considerable heterogeneity found in the analyses on the mean difference is evaluated in the univariate meta-regressions from Table 2 . The results show that the mean difference decreases with higher age and increases with higher aerobic capacity. The correlation is most likely explained in the association between age and aerobic capacity first described by Astrand; 26 thus, older patients will have lower aerobic capacity and lower mean difference between AC and LC. In general, the considerable heterogeneity and diversity in the results of the meta-analyses of the mean difference are explained mostly on the level of aerobic capacity (R 2 value above 90%). The univariate meta-regressions with negative adjusted R 2 values, presented in Table 2 , describe the mean difference poorly and thus, BMI, sex distribution, and difference in RER values cannot be not be used to explain the heterogeneity in the results. A significant positive association between the ratio of the results in L/min and mean age were found in Table 3 (P 5 .047); hence, older patients will have AC values closer to LC values, compared with younger patients. The results from Table 3 are affected by the wide CIs found in the analyses on the ratios. As no heterogeneity was found in Figures 5 and 6 , no R 2 could be calculated in Table 3 . However, the explanation of the association between the ratio and age is probably also found in the previously described correlation between aerobic capacity and age. 26 The included study of MacDonald et al 28 included borderline hypertensive patients and reported a higher physical fitness than the other studies. It could be argued that the included patients are only borderline CVD patients. 28 Four sensitivity analyses without the study were performed and in general the overall mean difference decreased and the overall ratio decreased. The results of the mean difference Figures 5 and 6 show that some individual patients with either PD or CVD will achieve a higher VO 2 value on AC, compared with the corresponding value on LC. The values reported in this article are on group level and it is expected that some individual patients will differ from the mean results.
Our results have some limitations as the main type of included studies was observational (prospective and retrospective) (according to Table 1 ). Such study designs lack any form of preplanned control to account for variables that may affect the results. None of the included articles described a random selection of patients and the possibility of selection bias is present. The risk of bias assessment also highlights the poor description of the target population, justification of sample size, and description of the statistical methods in the included studies. Especially, the study published by Martin et al 14 was assessed with high or unclear risk of bias in all of the items except the research question. According to the metaanalysis on the mean difference, the study by Martin et al 14 also reports the second highest mean difference in all of the included articles. However, except the above-mentioned study, we were not able to conclude whether risk of bias systematically affected our results toward an overestimation or underestimation of the mean difference or ratio. Another limitation is low generalizability to female patients because most of the included articles were performed on males or on mixed populations. The study by Carter et al 12 was the only study with a group of only female patients. However, the univariate meta-regressions on sex distribution do not indicate any affect by age on the mean difference nor on the ratio. Seven studies (with 7 groups) reported RER values.
14,29-34 Agespecific cuts for RER values are often used to determine whether the VO 2 outcome can be categorized as a maximum value. 35 Two of the 7 groups did not meet the age-specific criteria for maximal testing 32, 33 and 4 of the 7 groups did meet the age-specific criteria. 14, [29] [30] [31] 34 However, it did not seem to affect the results of the mean difference nor the ratio whether the RER criteria was met or not, but it should be stated that the VO 2 values from the studies of Owens et al and Franssen et al cannot be categorized as maximum values. 32, 33, 35 
CLINICAL IMPLICATIONS
Implication of AC in testing of patients with CVD is high and it is already commonly used. 1 Arm cycling is often used in patients with coronary artery disease due to exercise-induced claudication in LC testing. 1 Our results show that patients with CVD as well as patients with PD will obtain a more similar measure of physical fitness on the 2 exercise tests compared with healthy adults. 11 It is unknown whether the larger ratio between AC and LC among patients compared with healthy adults 11 is caused by patients being unable to reach the maximal aerobic capacity on LC, due to atrophy of the legs after inactivity or central limitations, or that the exercise-induced pain and discomfort is less on AC compared with LC. The results presented in this article support the implication of using AC in patients with CVD. Although the primary method of using CPET in patients with COPD is on the treadmill or with LC, 2 our results support using AC as an alternative for CPET. Whether these results can be used on other patient populations is unknown. However, it could be hypothesized that patients with central limitations such as CVD and PD will appear with the same results. New research should focus on mean difference and ratio and how the relationships between AC and LC values are affected by disease severity and also what exercise testing modality individual patients prefer.
The pooled ratio of 0.83 is larger than the ratio of 0.7 previously reported for healthy adults, 11 suggesting that differences between AC and LC are smaller in patient populations. The ratio between AC and LC is only significantly associated with age and thus, the ratio can be used in a clinical setting throughout an exercise program where patients are expected to enhance aerobic capacity. Furthermore, the pooled mean difference of 3.5 mL·kg 21 ·min 21 is smaller than the mean difference on 12.5 mL·kg 21 ·min 21 previously reported for healthy adults. 11 In conclusion, the results in this article show that patients with a low physical fitness will obtain more similar values on AC versus LC compared with patients with a higher physical fitness or healthy adults. 11 When the physical fitness and aerobic capacity is low among patients, the mean difference between test values from the AC and from the LC will also be low and the ratio between the tests will be large.
